BGG492 capsule

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BGG492 capsule, covering 2021-03-05 to 2021-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase II BGG492 Capsule Extension for Partial Epilepsy [Phase 2]